Home Business & Finance Ozempic Maker Novo Nordisk’s Investors Are Nervously...
Business & Finance

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Key Points

Novo’s share price is languishing about 70 percent below its peak from mid-2024, when it was Europe’s most valuable public company.

Novo’s share price is languishing about 70 percent below its peak from mid-2024, when it was Europe’s most valuable public company. [Image text:] NDC0169-4425-31 List442531 wegovy R 25 mg (semaglutide) Tablets 25 mg Rx only DISPENSE WITH MEDICATION GUIDE 30 tablets novo nordisk 25
Ozempic Maker Novo Nordisk’s (ORG) Europe (LOCATION)
Originally published by NYT Business Read original →